Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
As science evolves, so do disease names — and the stakes are higher than you'd think. From polycystic ovary syndrome to nonalcoholic fatty liver disease, outdated names can delay diagnoses, reinforce stigma, and muddy research. A growing movement in medicine is pushing for terminology that better reflects what we now know about complex, multisystem conditions.
Names matter in medicine — more than most people realize. Outdated or inaccurate disease names can shape how patients understand their condition, how clinicians approach care, and even what questions researchers choose to investigate. A growing body of evidence shows that poor medical nomenclature reinforces stigma and leads to fragmented, delayed care.
Two recent high-profile renamings illustrate the trend. Polycystic ovary syndrome (PCOS) was officially renamed polyendocrine metabolic ovarian syndrome following a 2026 International Consensus Process, reflecting its multisystem nature beyond just the ovaries. Similarly, nonalcoholic fatty liver disease was rebranded in 2023 as metabolic dysfunction-associated steatotic liver disease to better capture its metabolic roots and clinical severity.
Quick Facts:
Why it matters: When disease names don't match the science, real patients pay the price — through misdiagnosis, stigma, and gaps in care. Getting the language right is a foundational step toward more accurate, equitable, and comprehensive medicine.
